Vishala Neppalli, MD

PrintE-mail
Assistant Professor of Oncology
Roswell Park Cancer Institute

Profile

Areas of Expertise: 
Hematology
Hematopathology

Research

Research Interests: 
Molecular epidemiology of lymphomas
Classification and evaluation of prognostic markers in lymphoid malignancies

Background Information

Residency: 
2000-2003 - AP/CP Resident, University of Minnesota, Minneapolis, MN
Professional Experience: 
2010-Present - Assistant Professor of Oncology, Roswell Park Cancer Institute, Buffalo, NY
2006-2010 - Assistant Professor, Department of Pathology, University of Iowa
2005-2006 - Instructor/Senior Fellow, University of Nebraska Medical Center, Omaha, NE
Board Certification: 
Diplomate, American Board of Pathology- Hematology (Hematopathology)
Diplomate, American Board of Pathology
Education Commission for Foreign Medical Graduates
Fellowships: 
2004-2006 - Hematopathology Fellow, University of Nebraska Medical Center, NE
2003-2004 - Surgical Pathology Fellow, University of Minnesota, Minneapolis, MN
Professional Memberships: 
American Society of Hematology
Society of Hematopathology
International Lymphoma Epidemiology Consortium
United States and Canadian Academy of Pathology

Publications

Publications: 
  • Rutsch S, Neppalli VT, Shin D-M, DuBois W, Morse III HC, Goldschmidt H, Janz S. IL-6 and MYC collaborate in plasma cell tumor formation in mice. Blood 2010; 115(9):1746-54
  • Bhatt AP, Neppalli VT, Kelley EA, Schlueter AJ, Thomas CP. Dextran removal by plasmapheresis in a kidney-pancreas transplant recipient with dextran 40-induced osmotic nephrosis. American journal of kidney diseases 2011; 57(4):621-623
  • Baum CL, Link BK, Neppalli VT, Swick BL, Liu V. Reappraisal of the provisional entity primary cutaneous CD4+ small/medium pleomorphic T-cell lymphoma: a series of 10 adult and pediatric patients and review of the literature. Journal of the American Academy of Dermatology 2011; 65(4):739-748
  • Morton LM, Cerhan JR, Hartge P, Vasef MA, Neppalli VT, Natkunam Y, Dogan A, Dave BJ, Jain S, Levy R, Lossos IS, Cozen W, Davis S, Schenk MJ, Maurer MJ, Lynch CF, Rothman N, Chatterjee N, Yu K, Staudt LM, Weisenburger DD, Wang SS. Immunostaining to identify molecular subtypes of diffuse large B-cell lymphoma in a population-based epidemiologic study in the pre-rituximab era. International journal of molecular epidemiology and genetics 2011; 2(3):245-252
  • Lee EC, Fitzgerald M, Bannerman B, Donelan J, Bano K, Terkelsen J, Bradley DP, Subakan O, Silva MD, Liu R, Pickard M, Li Z, Tayber O, Li P, Hales P, Carsillo M, Neppalli VT, Berger AJ, Kupperman E, Manfredi M, Bolen JB, Van Ness B, Janz S. Antitumor activity of the investigational proteasome inhibitor MLN9708 in mouse models of B-cell and plasma cell malignancies. Clinical cancer research 2011; 17(23):7313-7323
  • Montgomery E, Chevalier A, Neppalli V. Potential Diagnostic Pitfalls Related to Bone Marrow Biopsy Quality in Staging Diffuse Large B-Cell Lymphoma. Laboratory investigation 2012; 92(Suppl. 1):504A